- Home
- NVS vs MS Comparison
NVS vs MS Comparison
Compare NVS & MS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVS
- MS
- Stock Information
- Founded
- NVS 1895
- MS 1924
- Country
- NVS Switzerland
- MS United States
- Employees
- NVS N/A
- MS N/A
- Industry
- NVS Biotechnology: Pharmaceutical Preparations
- MS Investment Bankers/Brokers/Service
- Sector
- NVS Health Care
- MS Finance
- Exchange
- NVS Nasdaq
- MS Nasdaq
- Market Cap
- NVS 254.8B
- MS 242.4B
- IPO Year
- NVS 1991
- MS N/A
- Fundamental
- Price
- NVS $126.71
- MS $163.63
- Analyst Decision
- NVS Hold
- MS Buy
- Analyst Count
- NVS 5
- MS 14
- Target Price
- NVS $119.00
- MS $167.38
- AVG Volume (30 Days)
- NVS 1.7M
- MS 5.7M
- Earning Date
- NVS 10-28-2025
- MS 10-15-2025
- Dividend Yield
- NVS 2.05%
- MS 2.45%
- EPS Growth
- NVS N/A
- MS 48.48
- EPS
- NVS 7.30
- MS 9.75
- Revenue
- NVS $56,372,000,000.00
- MS $68,532,000,000.00
- Revenue This Year
- NVS $9.44
- MS $17.50
- Revenue Next Year
- NVS $2.65
- MS $5.24
- P/E Ratio
- NVS $17.34
- MS $16.76
- Revenue Growth
- NVS 12.88
- MS 17.59
- 52 Week Low
- NVS $96.06
- MS $94.33
- 52 Week High
- NVS $133.55
- MS $167.13
- Technical
- Relative Strength Index (RSI)
- NVS 48.88
- MS 56.44
- Support Level
- NVS $121.57
- MS $160.86
- Resistance Level
- NVS $124.15
- MS $166.93
- Average True Range (ATR)
- NVS 1.62
- MS 3.21
- MACD
- NVS -0.49
- MS -0.03
- Stochastic Oscillator
- NVS 47.77
- MS 64.68
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.
About MS Morgan Stanley
Morgan Stanley is a massive global financial services firm, with offices in 42 countries and more than 80,000 employees as of year-end 2024. The firm cut its teeth in investment banking and institutional trading, where it maintains a strong presence today, but generates the lion share of its income from wealth and asset management franchises, where it boasted $7.9 trillion in client assets at the end of its most recent fiscal year. After reincorporation as a bank holding company in the wake of the great financial crisis, Morgan Stanley also boasts a top 10 banking franchise by deposits, with nearly $400 billion in customer deposits, predominately attributable to cash sweeps from its wealth management and brokerage businesses.